Abstract
Background: Type B thymoma is a complex heterogeneous disease with diverse pathological features and clinical outcomes. While it is among the most common tumors of the anterior mediastinum, there is so far no comprehensive proteomic study to understand the clinical behavior of these tumors. Data-independent acquisition (DIA) using high resolution mass spectrometer (MS) has emerged as a novel and powerful approach to quantify highly multiplexed proteins in clinical biopsy samples with high accuracy and reproducibility. Here, we report a large scale DIA-MS study to investigate the mechanism of Type B Thymomas across 34 clinical samples. The present study aimed to discover multiple proteins related to different subtypes of type B thymoma samples using label-free DIA-MS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
